| 2016 European Guidelines on cardiovascular disease prevention in clinical practice MF Piepoli International Journal of Behavioral Medicine 24 (3), 321, 2017 | 361* | 2017 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 324 | 2019 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 236 | 2019 |
| The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients P Poredoš, B Jug Angiology 58 (3), 309-315, 2007 | 206 | 2007 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 188 | 2021 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 168 | 2017 |
| Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, MT Cooney, ... Revista Española de Cardiología 69 (10), 939. e1-939. e87, 2016 | 149 | 2016 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 139 | 2018 |
| Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a … V Gyberg, D De Bacquer, K Kotseva, G De Backer, O Schnell, J Sundvall, ... European heart journal 36 (19), 1171-1177, 2015 | 122 | 2015 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 111 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 91 | 2020 |
| Blood flow restriction resistance exercise improves muscle strength and hemodynamics, but not vascular function in coronary artery disease patients: a pilot randomized … T Kambič, M Novaković, K Tomažin, V Strojnik, B Jug Frontiers in physiology 10, 656, 2019 | 83 | 2019 |
| Procoagulant state in heart failure with preserved left ventricular ejection fraction B Jug, N Vene, BG Salobir, M Šebeštjen, M Šabovic, I Keber International Heart Journal 50 (5), 591-600, 2009 | 76 | 2009 |
| Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure B Jug, BG Salobir, N Vene, M Šebeštjen, M Šabovič, I Keber Heart and vessels 24, 271-276, 2009 | 72 | 2009 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 61 | 2022 |
| Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement … G Ferrannini, D De Bacquer, G De Backer, K Kotseva, L Mellbin, D Wood, ... Diabetes care 43 (4), 726-733, 2020 | 60 | 2020 |
| The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial M Lunder, M Janić, B Jug, M Šabovič European Journal of Internal Medicine 23 (3), 261-266, 2012 | 51 | 2012 |
| Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry CJ Kapelios, C Laroche, MG Crespo‐Leiro, SD Anker, AJS Coats, ... European journal of heart failure 22 (8), 1424-1437, 2020 | 47 | 2020 |
| Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta della Società Europea di Cardiologia e di altre … MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ... Giornale italiano di cardiologia 18 (7), 547-612, 2017 | 45 | 2017 |
| Functional compared to anatomical imaging in the initial evaluation of patients with suspected coronary artery disease: An international, multi-center, randomized controlled … G Karthikeyan, BG Salobir, B Jug, N Devasenapathy, E Alexanderson, ... Journal of Nuclear Cardiology 24 (2), 507-517, 2017 | 44 | 2017 |
